The Provision of Individual Placement and Support (IPS) For Residents Who Access Drug and Alcohol Services in the City of Sunderland Council Area

Sunderland City Council · United Kingdom government procurement

Closed June 05, 2026. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

A contract for provision of an Individual Placement and Support Services (IPS) for Residents who Access Drug and Alcohol Services in the City of Sunderland Council Area.
The Sunderland IPS Scheme will be available to individuals of working age (16+), resident in the Sunderland area, who are engaged in structured treatment for drug and/or alcohol issues and are out of work. The 'structured treatment' can be provided by either a young person's community-based specialist substance use service; an adult's community-based specialist substance use service; or an 'all age' community-based specialist substance use service, (hereafter these services will be collectively referred to as 'specialist community drug and alcohol treatment services).
The Scheme will provide bespoke 'packages' of support to assist service users into sustainable, paid employment.

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencySunderland City Council
CountryUnited Kingdom
CategoryPharmaceuticals
CPV85100000
PublishedJune 05, 2026
Procurement stageRequest for Proposal (RFP)
ClosedJune 05, 2026
StatusClosed — no longer accepting responses
Official sourceView original notice
Last verifiedAugust 10, 2026

Contains public sector information licensed under the Open Government Licence v3.0. Source: UK Government (Find a Tender).

Browse Similar Open Opportunities in United Kingdom

Pharmaceutical Wholesale Services
Community Drug and Alcohol Services
Provision of Drug, Alcohol & DNA Testing Services Framework
Personalised Adaptive Medicine
Repurposing Epigenetic Therapy for Hypertrophic Cardiomyopathy to facilitate the innovation and growth of a N.Ireland Cardiac Drug Development Company
Smallpox Vaccine (2026)
Meningococcal ACWY vaccine (2027)
From Peptides to Mimetics: Towards Smaller More Stable Drug-like Protein-protein Interaction Inhibitors

See every United Kingdom Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Pharmaceuticals intelligence report in your inbox

A personalized report on United Kingdom Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.